Journal
ONCOGENE
Volume 19, Issue 43, Pages 4979-4987Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1203869
Keywords
tyrosine phosphatase; c-Src; PTP; breast cancer; tumor marker
Funding
- NCI NIH HHS [R29 CA68365, P30CA16087, 5R21 CA66229-04] Funding Source: Medline
Ask authors/readers for more resources
Tyrosine phosphorylation is controlled by a balance of tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), Whereas the contribution of PTKs to breast tumorigenesis is the subject of intense scrutiny, the potential role of PTPs is poorly known. RPTP alpha is implicated in the activation of Src family kinases, and regulation of integrin signaling, cell adhesion, and growth factor responsiveness. To explore its potential contribution to human neoplasia, we surveyed RPTPa protein levels in primary human breast cancer. We found RPTPa levels to vary widely among tumors, with 29% of cases manifesting significant overexpression, High RPTP alpha protein levels correlated significantly with low tumor grade and positive estrogen receptor status. Expression of RPTP alpha in breast carcinoma cells led to growth inhibition, associated with increased accumulation in G(0) and G(1), and delayed tumor growth and metastasis. To our knowledge, this is the first example of a study correlating expression level of a specific bona fide PTP with neoplastic disease status in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available